Round Two of the first federal trial challenging Merck's drug Vioxx will be Feb. 6 in New Orleans, U.S. District Judge Eldon Fallon told attorneys Friday. Fallon declared a mistrial in the case Dec. 12 after jurors deliberated for 18 hours over several days without a unanimous verdict. That left Merck with a win and a loss in two state trials -- and an undecided in the federal trial, which centers on the 2001 death of a seafood company manager who took Vioxx for about a month.
December 19, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Round Two of the nation’s first federal trial challenging safety of Merck & Co.’s drug Vioxx will be Feb. 6 in New Orleans, a judge told attorneys Friday.
U.S. District Judge Eldon Fallon of New Orleans held a private telephone conference with attorneys on both sides Friday to set the date and place to retry the case that ended Dec. 12 in a mistrial.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...
Exciting Career Opportunities at Nuzzo & Roberts! Nuzzo & Roberts, a leading mid-sized insurance defense firm based in Cheshire, CT...
